Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2020.07.16.206870v1?rss=1 Authors: Abou-Jaoude, A., Courtes, M., Badique, L., Elhaj Mahmoud, D., Abboud, C., Mlih, M., Justiniano, H., Lemle, A., Awan, S., Terrand, J., Niemeier, A., Barbero, A., Houard, X., Boucher, P., Matz, R. L. Abstract: Chondrocyte hypertrophic differentiation, a key process in endochondral ossification (EO), is also a feature of osteoarthritis leading to articular cartilage destruction. ShcA (Src homology and Collagen A) is an adaptor protein that binds to the cytoplasmic tail of receptor tyrosine kinases. We found that deletion of ShcA in chondrocytes of mice inhibits hypertrophic differentiation, alters the EO process, and leads to dwarfism. ShcA promotes ERK1/2 activation, nuclear translocation of the master transcription factor for chondrocyte hypertrophy, RunX2, while maintaining the Runx2 inhibitor YAP1 in its cytosolic inactive form. This leads to hypertrophic commitment and expression of markers of hypertrophy, such as Collagen X. In addition, ShcA deletion in chondrocytes protects from age-related osteoarthritis development in mice. Our results reveal that ShcA integrates multiple stimuli which affect the intracellular signaling processes leading to the hypertrophic commitment of chondrocytes and osteoarthritis. Copy rights belong to original authors. Visit the link for more info